EUVIMEDEUVIMED entdecken
Open Access

m 6 A‑modified HOXC10 promotes HNSCC progression via co‑activation of ADAM17/EGFR and Wnt/β‑catenin signaling

Yujuan Zhou, Qiang Huang, Chunping Wu, Ye Xu, Yang Guo, Xiaohui Yuan, Chengzhi Xu, Liang Zhou

International Journal of Oncology · 2023

DOI: 10.3892/ijo.2023.5598 ↗

Kurz gefasst

Fachartikel in der Zeitschrift International Journal of Oncology, 2023. Verfasst von Yujuan Zhou und 7 weiteren Autor:innen. Beteiligte Einrichtung: Department of Otorhinolaryngology, Eye and ENT Hospital, Fudan University, Shanghai 200031, P.R. China. Hauptthemen laut MEDLINE: ADAM17 Protein, Genes, Homeobox, Head and Neck Neoplasms, Homeodomain Proteins. Die Arbeit wurde bisher 11-mal zitiert (Crossref) und nennt 50 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Kein Abstract verfügbar.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

ADAM17 ProteinGenes, HomeoboxHead and Neck NeoplasmsHomeodomain ProteinsHumansbeta CateninCell Line, TumorCell ProliferationErbB ReceptorsGene Expression Regulation, NeoplasticRNARNA, MessengerSquamous Cell Carcinoma of Head and NeckWnt Signaling PathwayRNA MethylationAdenosine

Stichwörter der Autor:innen

N6‑methyladenosinea disintegrin and metalloproteinase 17head and neck squamous cell carcinomahomeobox C10ribosomal protein S15A

Substanzen

ADAM17 Proteinbeta CateninErbB ReceptorsHomeodomain ProteinsRNARNA, MessengerADAM17 protein, humanEGFR protein, humanHOXC10 protein, humanN-methyladenosine

Autor:innen und Institutionen

  • Department of Otorhinolaryngology, Eye and ENT Hospital, Fudan University, Shanghai 200031, P.R. China.
  • Liver Cancer Institute, Zhongshan Hospital, Fudan University and Key Laboratory of Carcinogenesis and Cancer Invasion, Ministry of Education, Shanghai 200032, P.R. China.

Zitieren

APA

Zhou, Y., Huang, Q., Wu, C., Xu, Y., Guo, Y., Yuan, X., Xu, C., & Zhou, L. (2023). m 6 A‑modified HOXC10 promotes HNSCC progression via co‑activation of ADAM17/EGFR and Wnt/β‑catenin signaling. International Journal of Oncology. https://doi.org/10.3892/ijo.2023.5598

Vancouver

Zhou Y, Huang Q, Wu C, Xu Y, Guo Y, Yuan X, et al. m 6 A‑modified HOXC10 promotes HNSCC progression via co‑activation of ADAM17/EGFR and Wnt/β‑catenin signaling. International Journal of Oncology. 2023. doi:10.3892/ijo.2023.5598

BibTeX
@article{Zhou2023,
  author = {Zhou, Yujuan and Huang, Qiang and Wu, Chunping and Xu, Ye and Guo, Yang and Yuan, Xiaohui and Xu, Chengzhi and Zhou, Liang},
  title = {m 6 A‑modified HOXC10 promotes HNSCC progression via co‑activation of ADAM17/EGFR and Wnt/β‑catenin signaling},
  journal = {International Journal of Oncology},
  year = {2023},
  doi = {10.3892/ijo.2023.5598}
}
Kostenlos starten →